City View Green Holdings - CEO, Rob Fia.
CEO, Rob Fia.
Source: City View Green Holdings.
  • City View (CVGR) has secured a purchase order from a national medical cannabis producer and distributor
  • The initial order involves the production of two cannabis-infused sauces
  • The company is in discussions with the client and other licensed producers to manufacture a diverse array of cannabis-infused edibles
  • Potential investors can expect news about new products under the company’s own brand in the coming weeks
  • City View Green Holdings is a consumer packaged goods company developing cannabis-infused edibles
  • City View (CVGR) is unchanged trading at $0.025 per share

City View (CVGR) has secured a purchase order from a national medical cannabis producer and distributor.

The initial order involves producing two cannabis-infused sauces – chocolate and caramel – to be made available through the client’s online portal and retail channel partners throughout Canada.

The purchase order marks the first sales revenue for the company, with additional orders expected to follow.

City View has been working with the client since December 2021. They are currently discussing developing additional white-labelled cannabis-infused products for regulatory approval.

Ongoing discussions with other licensed producers involve the manufacturing of cannabis-infused chocolates, baked goods, sauces and gummies.

City View has also received regulatory approval for four cannabis-infused edibles for its own brand with formal announcements forthcoming over the next few weeks.

“Our white-label cannabis-infused consumables model is coming to fruition with our first product sale to one of Canada’s most reputable licensed producers,” stated Rob Fia, CEO of City View. “We are honored to partner with this client due to their brand reputation and their products’ popularity across the Canadian marketplace.”

City View Green Holdings is a consumer packaged goods company developing cannabis-infused edibles.

City View (CVGR) is unchanged trading at $0.025 per share as of 11:45 am EST.

More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.

Canopy Growth prepares for U.S. expansion with new acquisitions

Canopy Growth (TSX:WEED) exercises its options to acquire Wana and Jetty Extracts, key players in the company's U.S. expansion strategy.